The Health and Economic Benefits of Influenza Vaccination for Healthy and At-Risk Persons Aged 65 to 74 Years

被引：0
|
作者：
Kristin L. Nichol
Michael Goodman
机构：
[1] University of Minnesota and Minneapolis VA Medical Center (111),
[2] Health Partners Research Foundation,undefined
来源：
PharmacoEconomics | 1999年 / 16卷
关键词：
Influenza; Adis International Limited; Influenza Vaccine; Influenza Vaccination; Healthy Person;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: The objective of this study was to assess the health and economic benefits of influenza vaccination in both healthy and at-risk seniors aged 65 to 74 years.
引用
收藏
页码：63 / 71
页数：8
相关论文
共 43 条
  • [1] Cost effectiveness of influenza vaccination for healthy persons between ages 65 and 74 years
    Nichol, KL
    Goodman, M
    VACCINE, 2002, 20 : S21 - S24
  • [2] Clinical and economic impact of influenza vaccination on healthy children aged 2-5 years
    Esposito, S
    Marchisio, P
    Bosis, S
    Lambertini, L
    Claut, L
    Faelli, N
    Bianchi, C
    Colombo, GL
    Principi, N
    VACCINE, 2006, 24 (05) : 629 - 635
  • [3] Cost-Effectiveness of Influenza Vaccination Strategies in Adults: Older Adults Aged ≥65 Years, Adults Aged 50-64 Years, and At-Risk Adults Aged 19-64 Years
    Choi, Min Joo
    Shin, Gyeongseon
    Kang, Daewon
    Lim, Jae-Ok
    Kim, Yun-Kyung
    Choi, Won Suk
    Yun, Jae-Won
    Noh, Ji Yun
    Song, Joon Young
    Kim, Woo Joo
    Choi, Sang-Eun
    Cheong, Hee Jin
    VACCINES, 2022, 10 (03)
  • [4] Is influenza vaccination cost effective for healthy people between ages 65 and 74 years? A randomised controlled trial
    Allsup, S
    Haycox, A
    Regan, M
    Gosney, M
    VACCINE, 2004, 23 (05) : 639 - 645
  • [5] Benefits of influenza vaccination among healthy and high-risk persons across the age spectrum
    Nichol, KL
    OPTIONS FOR THE CONTROL OF INFLUENZA V, 2004, 1263 : 48 - 50
  • [6] Public Health and Economic Benefits of Influenza Vaccination of the Population Aged 50 to 59 Years without Risk Factors for Influenza Complications in Mexico: A Cross-Sectional Epidemiological Study
    Betancourt-Cravioto, Miguel
    Falcon-Lezama, Jorge Abelardo
    Saucedo-Martinez, Rodrigo
    Alfaro-Cortes, Myrna Maria
    Tapia-Conyer, Roberto
    VACCINES, 2021, 9 (03) : 1 - 20
  • [7] Effect of influenza vaccination on hospitalizations in persons aged 50 years and older
    Baxter, Roger
    Ray, G. Thomas
    Fireman, Bruce H.
    VACCINE, 2010, 28 (45) : 7267 - 7272
  • [8] Factors associated with pneumococcal and influenza vaccination in hospitalized people aged ≥65 years
    Sintes, X.
    Nebot, M.
    Izquierdo, C.
    Ruiz, L.
    Dominguez, A.
    Bayas, J. M.
    Vera, I.
    Carratala, J.
    Sousa, D.
    EPIDEMIOLOGY AND INFECTION, 2011, 139 (05) : 666 - 673
  • [9] Implementing an Influenza Vaccination Programme for Adults Aged ≥ 65 Years in PolandA Cost-Effectiveness Analysis
    Lidia Brydak
    Julie Roiz
    Pascaline Faivre
    Camille Reygrobellet
    Clinical Drug Investigation, 2012, 32 : 73 - 85
  • [10] Serologic response to sequential vaccination with enhanced influenza vaccines: Open label randomized trial among adults aged 65-74 years
    McLean, Huong Q.
    Levine, Min Z.
    King, Jennifer P.
    Flannery, Brendan
    Belongia, Edward A.
    VACCINE, 2021, 39 (49) : 7146 - 7152
12345